Activation of neurotensin receptor type 1 attenuates locomotor activity

Neuropharmacology

Volumn 85, Issue , 2014, Pages 482-492

  Vadnie, Chelsea A ^a,b   Hinton, David J ^a,b   Choi, Sun ^b   Choi, Yubin ^b   Ruby, Christina L ^b,d   Oliveros, Alfredo ^b   Prieto, Miguel L ^a,c   Park, Jun Hyun ^b,e   Choi, Doo Sup ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSIDAD DE LOS ANDES   (Chile)

^d INDIANA UNIVERSITY OF PENNSYLVANIA   (United States)

^e Inje University College of Medicine   (South Korea)

Author keywords

D2R; Locomotor activity; Neurotensin; NTS1; Nucleus accumbens; PD149163

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BROMOCRIPTINE; DOPAMINE; N2 (2,6 DIAMINOHEXYL)LYSYLPROLYLTRYPTOPHYL 3 METHYLVALYLLEUCINE ETHYL ESTER; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR TYPE 1; UNCLASSIFIED DRUG; BENZAZEPINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROTENSIN; NEUROTENSIN TYPE 1 RECEPTOR; SK&F 81297;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG MECHANISM; EXPERIMENTAL HYPERACTIVITY; EXPERIMENTAL HYPOACTIVITY; GRIP STRENGTH; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL HOUSING; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; DRUG TOLERANCE; ENVIRONMENT; METABOLISM; MICROINJECTION; MOTOR ACTIVITY; MUSCLE STRENGTH; PHYSIOLOGY; RANDOMIZATION; ROTAROD TEST;

ANIMALS; BENZAZEPINES; BROMOCRIPTINE; CENTRAL NERVOUS SYSTEM AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; ENVIRONMENT; HOUSING, ANIMAL; MALE; MICE, INBRED C57BL; MICROINJECTIONS; MOTOR ACTIVITY; MUSCLE STRENGTH; NEUROTENSIN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RANDOM ALLOCATION; RECEPTORS, DOPAMINE; RECEPTORS, NEUROTENSIN; ROTAROD PERFORMANCE TEST;

EID: 84903522296     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.05.046     Document Type: Article

References (66)

1. L.F. Agnati, K. Fuxe, F. Benfenati, and N. Battistini Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N- propylnorapomorphine binding sites Acta Physiol. Scand. 119 1983 459 461 (Pubitemid 14214775)
2. E.B. Binder, B. Kinkead, M.J. Owens, and C.B. Nemeroff Neurotensin and dopamine interactions Pharmacol. Rev. 53 2001 453 486 (Pubitemid 33136236)
3. D.O. Borroto-Escuela, A. Ravani, A.O. Tarakanov, I. Brito, M. Narvaez, W. Romero-Fernandez, F. Corrales, L.F. Agnati, S. Tanganelli, L. Ferraro, and K. Fuxe Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers Biochem Biophys. Res. Commun. 435 2013 140 146
4. H. Boudin, D. Pelaprat, W. Rostene, and A. Beaudet Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor J. Comp. Neurol. 373 1996 76 89 (Pubitemid 26292120)
5. M. Boules, P. Fredrickson, and E. Richelson Bioactive analogs of neurotensin: focus on CNS effects Peptides 27 2006 2523 2533 (Pubitemid 44402792)
6. M. Boules, Z. Li, K. Smith, P. Fredrickson, and E. Richelson Diverse roles of neurotensin agonists in the central nervous system Front. Endocrinol. 4 2013 36
7. M. Boules, B. McMahon, R. Wang, L. Warrington, J. Stewart, S. Yerbury, A. Fauq, D. McCormick, and E. Richelson Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier Brain Res. 987 2003 39 48 (Pubitemid 37267885)
8. A.V. Buhler, J. Choi, H.K. Proudfit, and G.F. Gebhart Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive Pain 114 2005 285 294 (Pubitemid 40279111)
9. R. Carraway, and S.E. Leeman The amino acid sequence of a hypothalamic peptide, neurotensin J. Biol. Chem. 250 1975 1907 1911
10. P. Chalon, N. Vita, M. Kaghad, M. Guillemot, J. Bonnin, B. Delpech, G. Le Fur, P. Ferrara, and D. Caput Molecular cloning of a levocabastine-sensitive neurotensin binding site FEBS Lett. 386 1996 91 94 (Pubitemid 26173063)
11. A. Cipriani, C. Barbui, G. Salanti, J. Rendell, R. Brown, S. Stockton, M. Purgato, L.M. Spineli, G.M. Goodwin, and J.R. Geddes Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet 378 2011 1306 1315
12. 2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice Eur. J. Pharmacol. 364 1999 175 182
13. B.A. Donzanti, and N.J. Uretsky Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: possible dependence on dopaminergic mechanisms Neuropharmacology 22 1983 971 981 (Pubitemid 13039232)
14. P.J. Elliott, J. Chan, Y.M. Parker, and C.B. Nemeroff Behavioral effects of neurotensin in the open field: structure-activity studies Brain Res. 381 1986 259 265 (Pubitemid 16032298)
15. G.N. Ervin, L.S. Birkemo, C.B. Nemeroff, and A.J. Prange Jr. Neurotensin blocks certain amphetamine-induced behaviours Nature 291 1981 73 76 (Pubitemid 11125256)
16. D. Feifel, G. Melendez, R.J. Murray, D.N. Tina Tran, M.A. Rullan, and P.D. Shilling The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance Psychopharmacol. Berl. 200 2008 197 203
17. D. Feifel, Z. Pang, P.D. Shilling, G. Melendez, R. Schreiber, and D. Button Sensorimotor gating in neurotensin-1 receptor null mice Neuropharmacology 58 2010 173 178
18. J.S. Fink, and G.P. Smith Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats Brain Res. 199 1980 359 384 (Pubitemid 10055940)
19. K. Gao, D.E. Kemp, S.J. Ganocy, P. Gajwani, G. Xia, and J.R. Calabrese Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review J. Clin. Psychopharmacol. 28 2008 203 209 (Pubitemid 351417126)
20. G. Grunder, A. Carlsson, and D.F. Wong Mechanism of new antipsychotic medications: occupancy is not just antagonism Arch. Gen. Psychiatry 60 2003 974 977 (Pubitemid 37222078)
21. M.K. Hadden, K.S. Orwig, K.P. Kokko, J. Mazella, and T.A. Dix Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues Neuropharmacology 49 2005 1149 1159 (Pubitemid 41608639)
22. M.D. Humphries, and T.J. Prescott The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward Prog. Neurobiol. 90 2010 385 417
23. S. Ikemoto Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists Neuroscience 113 2002 939 955 (Pubitemid 35245262)
24. C. Jomphe, P.L. Lemelin, H. Okano, K. Kobayashi, and L.E. Trudeau Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons Eur. J. Neurosci. 24 2006 2789 2800 (Pubitemid 44813830)
25. P.W. Kalivas, C.B. Nemeroff, and A.J. Prange Jr. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin Eur. J. Pharmacol. 78 1982 471 474 (Pubitemid 12143018)
26. P.W. Kalivas, C.B. Nemeroff, and A.J. Prange Jr. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing Neuroscience 11 1984 919 930 (Pubitemid 14111182)
27. M.A. Kelly, M. Rubinstein, T.J. Phillips, C.N. Lessov, S. Burkhart-Kasch, G. Zhang, J.R. Bunzow, Y. Fang, G.A. Gerhardt, D.K. Grandy, and M.J. Low Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations J. Neurosci. 18 1998 3470 3479 (Pubitemid 28186038)
28. P.H. Kelly, R.J. Miller, and J.L. Neumeyer Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens Eur. J. Pharmacol. 35 1976 85 92
29. F. Klinker, K. Hasan, W. Paulus, M.A. Nitsche, and D. Liebetanz Pharmacological blockade and genetic absence of the dopamine D2 receptor specifically modulate voluntary locomotor activity in mice Behav. Brain Res. 242 2013 117 124
30. S. Koschatzky, N. Tschammer, and P. Gmeiner Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics ACS Chem. Neurosci. 2 2011 308 316
31. P.D. Lambert, R. Gross, C.B. Nemeroff, and C.D. Kilts Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system Ann. N. Y. Acad. Sci. 757 1995 377 389
32. M.R. Lee, D.J. Hinton, J.Y. Song, K.W. Lee, C. Choo, H. Johng, S.S. Unal, E. Richelson, and D.S. Choi Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice Pharmacol. Biochem Behav. 95 2010 235 241
33. X.M. Li, L. Ferraro, S. Tanganelli, W.T. O'Connor, U. Hasselrot, U. Ungerstedt, and K. Fuxe Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study J. Neural Transm. Gen. Sect. 102 1995 125 137
34. Y. Liang, M. Boules, Z. Li, K. Williams, T. Miura, A. Oliveros, and E. Richelson Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice Neuropharmacology 58 2010 1199 1205
35. J. Mazella, and J.P. Vincent Functional roles of the NTS2 and NTS3 receptors Peptides 27 2006 2469 2475 (Pubitemid 44425363)
36. J. Mazella, N. Zsurger, V. Navarro, J. Chabry, M. Kaghad, D. Caput, P. Ferrara, N. Vita, D. Gully, J.P. Maffrand, and J.P. Vincent The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor J. Biol. Chem. 273 1998 26273 26276 (Pubitemid 28471624)
37. G. Meisenberg, and W.H. Simmons Motor hypoactivity induced by neurotensin and related peptides in mice Pharmacol. Biochem Behav. 22 1985 189 193 (Pubitemid 15132098)
38. M. Mendez, F. Souaze, M. Nagano, P.A. Kelly, W. Rostene, and P. Forgez High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR J. Mol. Neurosci. 9 1997 93 102 (Pubitemid 127499159)
39. K.M. Merchant, and D.M. Dorsa Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics Proc. Natl. Acad. Sci. U. S. A. 90 1993 3447 3451 (Pubitemid 23111383)
40. A. Minassian, B.L. Henry, M.A. Geyer, M.P. Paulus, J.W. Young, and W. Perry The quantitative assessment of motor activity in mania and schizophrenia J. Affect Disord. 120 2010 200 206
41. G.J. Mogenson, D.L. Jones, and C.Y. Yim From motivation to action: functional interface between the limbic system and the motor system Prog. Neurobiol. 14 1980 69 97 (Pubitemid 10053405)
42. R. Morgenstern, T. Mende, R. Gold, P. Lemme, and W. Oelssner Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens Pharmacol. Biochem. Behav. 21 1984 501 506 (Pubitemid 14024606)
43. C.B. Nemeroff, G. Bissette, A.J. Prange Jr., P.T. Loosen, T.S. Barlow, and M.A. Lipton Neurotensin: central nervous system effects of a hypothalamic peptide Brain Res. 128 1977 485 496 (Pubitemid 8136671)
44. C.B. Nemeroff, D.E. Hernandez, D. Luttinger, P.W. Kalivas, and A.J. Prange Jr. Interactions of neurotensin with brain dopamine systems Ann. N. Y. Acad. Sci. 400 1982 330 344 (Pubitemid 13138584)
45. S.M. Nicola The nucleus accumbens as part of a basal ganglia action selection circuit Psychopharmacol. Berl. 191 2007 521 550 (Pubitemid 46355879)
46. C. Norman, S.R. Beckett, C.H. Spicer, D. Ashton, X. Langlois, and G.W. Bennett Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion J. Psychopharmacol. 22 2008 300 307 (Pubitemid 351847450)
47. I. Peltonen, T.T. Myohanen, and P.T. Mannisto Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways Neurochem. Res. 37 2012 2033 2041
48. C.M. Pennartz, H.J. Groenewegen, and F.H. Lopes da Silva The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data Prog. Neurobiol. 42 1994 719 761 (Pubitemid 24199524)
49. R.H. Perlis, J.A. Welge, L.A. Vornik, R.M. Hirschfeld, and P.E. Keck Jr. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials J. Clin. Psychiatry 67 2006 509 516 (Pubitemid 43764227)
50. K.A. Petrie, M. Bubser, C.D. Casey, M.D. Davis, B.L. Roth, and A.Y. Deutch The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat Neuropsychopharmacology 29 2004 1878 1888 (Pubitemid 39336799)
51. K.A. Petrie, D. Schmidt, M. Bubser, J. Fadel, R.E. Carraway, and A.Y. Deutch Neurotensin activates GABAergic interneurons in the prefrontal cortex J. Neurosci. 25 2005 1629 1636 (Pubitemid 40279267)
52. D.J. Pettibone, J.F. Hess, P.J. Hey, M.A. Jacobson, M. Leviten, E.V. Lis, P.J. Mallorga, D.M. Pascarella, M.A. Snyder, J.B. Williams, and Z. Zeng The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin J. Pharmacol. Exp. Ther. 300 2002 305 313 (Pubitemid 34028541)
53. V.M. Pickel, J. Chan, K.T. Delle Donne, H. Boudin, D. Pelaprat, and W. Rostene High-affinity neurotensin receptors in the rat nucleus accumbens: subcellular targeting and relation to endogenous ligand J. Comp. Neurol. 435 2001 142 155 (Pubitemid 32480004)
54. C.J. Pycock, and R.W. Horton Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens J. Neural Transm. 45 1979 17 33 (Pubitemid 9174612)
55. R.A. Radcliffe, and V.G. Erwin Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex J. Pharmacol. Exp. Ther. 277 1996 1467 1476 (Pubitemid 27167161)
56. A. Remaury, N. Vita, S. Gendreau, M. Jung, M. Arnone, M. Poncelet, J.M. Culouscou, G. Le Fur, P. Soubrie, D. Caput, D. Shire, M. Kopf, and P. Ferrara Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia Brain Res. 953 2002 63 72 (Pubitemid 35217808)
57. G.J. Rinkel, E.C. Hoeke, and T.B. van Wimersma Greidanus Elective tolerance to behavioral effects of neurotensin Physiol. Behav. 31 1983 467 470 (Pubitemid 13018473)
58. P. Robledo, R. Maldonado, and G.F. Koob Neurotensin injected into the nucleus-accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat Brain Res. 622 1993 105 112 (Pubitemid 23264954)
59. R.K. Schwarting, and J.P. Huston The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments Prog. Neurobiol. 50 1996 275 331 (Pubitemid 26412599)
60. R. Steinberg, P. Brun, M. Fournier, J. Souilhac, D. Rodier, G. Mons, J.P. Terranova, G. Le Fur, and P. Soubrie SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission Neuroscience 59 1994 921 929 (Pubitemid 24149101)
61. S.A. Taha, S.M. Nicola, and H.L. Fields Cue-evoked encoding of movement planning and execution in the rat nucleus accumbens J. Physiol. 584 2007 801 818 (Pubitemid 350031924)
62. K. Tanaka, M. Masu, and S. Nakanishi Structure and functional expression of the cloned rat neurotensin receptor Neuron 4 1990 847 854 (Pubitemid 20208510)
63. D. Thibault, P.R. Albert, G. Pineyro, and L.E. Trudeau Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism J. Biol. Chem. 286 2011 9174 9184
64. X.M. Wang, and B.M. Evers Characterization of early developmental pattern of expression of neurotensin/neuromedin N gene in foregut and midgut Dig. Dis. Sci. 44 1999 33 40 (Pubitemid 29053075)
65. D.J. Wustrow, M.D. Davis, H.C. Akunne, A.E. Corbin, J.N. Wiley, L.D. Wise, and T.G. Heffner Reduced amide bond neurotensin-8-13 mimetics with potent in-vivo activity Bioorg Med. Chem. Lett. 5 1995 997 1002
66. X. Zhuang, R.S. Oosting, S.R. Jones, R.R. Gainetdinov, G.W. Miller, M.G. Caron, and R. Hen Hyperactivity and impaired response habituation in hyperdopaminergic mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 1982 1987 (Pubitemid 32165609)